{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:49:24Z","timestamp":1791758964421,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jcpo.2025.100633","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:27:20Z","timestamp":1754954840000},"page":"100633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Navigating cost and care: A qualitative study on oncologists\u2019 perspectives on financial toxicity in India"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-6031","authenticated-orcid":false,"given":"Parth","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vid","family":"Karmarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-8835","authenticated-orcid":false,"given":"Pooja","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcpo.2025.100633_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.jcpo.2025.100633_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.31557\/APJCP.2021.22.3.671","article-title":"Out-of-Pocket, catastrophic health expenditure and distress financing on Non-Communicable diseases in India: a systematic review with Meta-Analysis","volume":"22","author":"Dhankhar","year":"2021","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.jcpo.2025.100633_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamaoncol.2016.4865","article-title":"Out-of-Pocket spending and financial burden among Medicare beneficiaries with cancer","volume":"3","author":"Narang","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jcpo.2025.100633_bib4","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcpo.2025.100633_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrc3237","article-title":"Combining immunotherapy and targeted therapies in cancer treatment","volume":"12","author":"Vanneman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jcpo.2025.100633_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.trecan.2021.12.007","article-title":"Role of financial toxicity in perpetuating health disparities","volume":"8","author":"Shah","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jcpo.2025.100633_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.9012","article-title":"Checkpoint inhibitor accessibility in 15,000+ Indian patients: 2022 ASCO annual meeting","volume":"40","author":"Ravikrishna","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2025.100633_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/OP.23.00434","article-title":"Financial toxicity and Health-Related quality of life profile of patients with hematologic malignancies treated in a universal health care system","volume":"20","author":"Sparano","year":"2024","journal-title":"JCO Oncol. Pr."},{"key":"10.1016\/j.jcpo.2025.100633_bib9","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1016\/S1470-2045(21)00468-X","article-title":"Financial toxicity in cancer care in India: a systematic review","volume":"22","author":"Boby","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcpo.2025.100633_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1065737","article-title":"Financial toxicity of cancer treatment in India: towards closing the cancer care gap","volume":"11","author":"Prinja","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jcpo.2025.100633_bib11","first-page":"7159","article-title":"Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis","volume":"30","author":"Donkor","year":"2022","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"10.1016\/j.jcpo.2025.100633_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084148","article-title":"Financial toxicity of cancer care in sub-Saharan Africa: protocol for a systematic review","volume":"14","author":"Ida","year":"2024","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.jcpo.2025.100633_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int. J. Qual. Health care"},{"key":"10.1016\/j.jcpo.2025.100633_bib14","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.14694\/EdBook_AM.2014.34.e146","article-title":"Value of cancer care: ethical considerations for the practicing oncologist","author":"Jagsi","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book Am. Soc. Clin. Oncol. Annu. Meet."},{"key":"10.1016\/j.jcpo.2025.100633_bib15","doi-asserted-by":"crossref","first-page":"18133","DOI":"10.1002\/cam4.6375","article-title":"Factors influencing treatment decision-making for cancer patients in low- and middle-income countries: a scoping review","volume":"12","author":"Salek","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jcpo.2025.100633_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/10436596241230998","article-title":"Dominant worldviews, institutional, and contextual factors affecting cancer care: evidence from an institutional ethnonursing study in Nigeria","volume":"35","author":"Nwozichi","year":"2024","journal-title":"J. Transcult. Nurs. Off. J. Transcult. Nurs. Soc."},{"key":"10.1016\/j.jcpo.2025.100633_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/WBJC.WBJC_4_24","article-title":"Ethical issues and distressing aspects regularly faced by healthcare professionals in the care of pediatric cancer patients in Indian context: a narrative review from a bioethics consortium","volume":"3","author":"Baliga","year":"2023","journal-title":"Bengal J. Cancer"},{"key":"10.1016\/j.jcpo.2025.100633_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/jehp.jehp_1048_23","article-title":"Ethical and moral principles for oncology healthcare workers: a brief report from a bioethics consortium emphasizing on need for education","volume":"13","author":"Baliga","year":"2024","journal-title":"J. Educ. Health Promot"},{"key":"10.1016\/j.jcpo.2025.100633_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacr.2022.10.011","article-title":"Defining the role of the modern oncology provider in mitigating financial toxicity","volume":"20","author":"Su","year":"2023","journal-title":"J. Am. Coll. Radio."},{"key":"10.1016\/j.jcpo.2025.100633_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015700","article-title":"Disparities in availability of new cancer drugs worldwide: 1990-2022","volume":"9","author":"Li","year":"2024","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.jcpo.2025.100633_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3332\/ecancer.2019.911","article-title":"Ethics of cancer care: beyond biology and Medicine","volume":"13","author":"Ghose","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jcpo.2025.100633_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000509119","article-title":"Principles of clinical ethics and their application to practice","volume":"30","author":"Varkey","year":"2021","journal-title":"Med. Princ. Pr."},{"key":"10.1016\/j.jcpo.2025.100633_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13193-020-01247-8","article-title":"Low cost, low dose, oral, neoadjuvant chemotherapy protocol in locally advanced borderline oral Cancers\u2014Feasibility study","volume":"12","author":"Sultania","year":"2021","journal-title":"Indian J. Surg. Oncol."},{"key":"10.1016\/j.jcpo.2025.100633_bib24","unstructured":"Low Dose of Cancer Immunotherapy Effective in Trial in India - NCI, (2022). \u3008https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2022\/cancer-immunotherapy-low-dose\u3009 (accessed June 2, 2025)."},{"key":"10.1016\/j.jcpo.2025.100633_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bju.16092","article-title":"Drug costs: acquisition costs are critical but not the entire story of financial toxicity","volume":"132","author":"Kaye","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.jcpo.2025.100633_bib26","first-page":"339","article-title":"Financial hardship, financial toxicity, and transportation challenges among older cancer survivors treated with curative-intent surgery","volume":"33","author":"Myers","year":"2025","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jcpo.2025.100633_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkae093","article-title":"The intersection of travel burdens and financial hardship in cancer care: a scoping review","volume":"8","author":"Planey","year":"2024","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.jcpo.2025.100633_bib28","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.21.01636","article-title":"Risk of adverse financial events in patients with cancer: evidence from a novel linkage between cancer registry and credit records","volume":"40","author":"Shankaran","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2025.100633_bib29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.trecan.2018.07.006","article-title":"Balancing the economics and ethics of personalised oncology","volume":"4","author":"Flaum","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jcpo.2025.100633_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1634\/theoncologist.2013-0078","article-title":"The cost of cancer Care\u2014Balancing our duties to patients versus society: are they mutually exclusive?","volume":"18","author":"Kumar","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jcpo.2025.100633_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1266533","article-title":"Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis","volume":"11","author":"Azzani","year":"2024","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jcpo.2025.100633_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11673-024-10342-2","article-title":"Should patients be allowed to pay out of pocket? The ethical dilemma of access to expensive Anti-cancer treatments in universal healthcare systems: a Dutch case study","volume":"21","author":"Bomhof","year":"2024","journal-title":"J. Bioethical Inq."},{"key":"10.1016\/j.jcpo.2025.100633_bib33","unstructured":"A. Belloni, The cost of cancer: what does it mean for the UK economy?, Cancer Res. UK - Cancer News (2024). \u3008https:\/\/news.cancerresearchuk.org\/2024\/11\/21\/the-cost-of-cancer-economy-uk-growth-mission-oecd-report\/\u3009 (accessed June 2, 2025)."},{"key":"10.1016\/j.jcpo.2025.100633_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2021.08.001","article-title":"Financial toxicity and shared decision making in oncology","volume":"31","author":"Greenup","year":"2022","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.jcpo.2025.100633_bib35","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1186\/s12885-021-08697-5","article-title":"Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines","volume":"21","author":"Agarwal","year":"2021","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.jcpo.2025.100633_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/GO.24.00039","article-title":"Local sociocultural practice specific financial toxicity assessment tool for cancer: an emerging need","author":"Sharma","year":"2024","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.jcpo.2025.100633_bib37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.6004\/jnccn.2022.7067","article-title":"No money, Mo\u2019 problems: financial toxicity in the realm of cancer screening","volume":"20","author":"Patel","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.jcpo.2025.100633_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.6004\/jnccn.2024.7030","article-title":"Impact of a comprehensive financial navigation intervention to reduce Cancer-Related financial toxicity","volume":"22","author":"Wheeler","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.jcpo.2025.100633_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.6004\/jnccn.2025.7010","article-title":"The financial toxicity tumor board: 5-Year update on practice and a guide to implementation","volume":"23","author":"Knight","year":"2025","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.jcpo.2025.100633_bib40","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.22.01799","article-title":"Financial toxicity in cancer care: implications for clinical care and potential practice solutions","volume":"41","author":"Khan","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2025.100633_bib41","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/tbm\/ibab091","article-title":"Financial toxicity in cancer care: origins, impact, and solutions","volume":"11","author":"Abrams","year":"2021","journal-title":"Transl. Behav. Med."},{"key":"10.1016\/j.jcpo.2025.100633_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1200\/OP.24.00375","article-title":"Interventions to address Cancer-Related financial hardship: a scoping review and call to action","volume":"21","author":"Wheeler","year":"2025","journal-title":"JCO Oncol. Pr."},{"key":"10.1016\/j.jcpo.2025.100633_bib43","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3332\/ecancer.2025.1837","article-title":"An evaluation of the adequacy of Indian national and state essential medicines lists (EMLs) for palliative care medical needs\u2014a comparative analysis","volume":"19","author":"Agrawal","year":"2025","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.jcpo.2025.100633_bib44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/10499091241268585","article-title":"End of life care practices at a tertiary cancer centre in India: an observational study","volume":"42","author":"Maurya","year":"2025","journal-title":"Am. J. Hosp. Palliat. Med."},{"key":"10.1016\/j.jcpo.2025.100633_bib45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic Non\u2013Small-Cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcpo.2025.100633_bib46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2471\/BLT.23.289714","article-title":"A national cancer grid pooled procurement initiative, India","volume":"101","author":"Pramesh","year":"2023","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.jcpo.2025.100633_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004332","article-title":"Price negotiation and pricing of anticancer drugs in China: an observational study","volume":"21","author":"Zhou","year":"2024","journal-title":"PLoS Med"},{"key":"10.1016\/j.jcpo.2025.100633_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-8603-10-3","article-title":"To patent or not to patent? The case of Novartis\u2019 cancer drug glivec in India","volume":"10","author":"Gabble","year":"2014","journal-title":"Glob. Health"},{"key":"10.1016\/j.jcpo.2025.100633_bib49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.mayocp.2012.07.007","article-title":"The high cost of cancer drugs and what we can do about it","volume":"87","author":"Siddiqui","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jcpo.2025.100633_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JGO.2015.000570","article-title":"Novel humanitarian aid program: the glivec international patient assistance Program\u2014Lessons learned from providing access to breakthrough targeted oncology treatment in Low- and Middle-Income countries","volume":"1","author":"Garcia-Gonzalez","year":"2015","journal-title":"J. Glob. Oncol."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538325000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538325000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:13:07Z","timestamp":1772899987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538325000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"alternative-id":["S2213538325000773"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2025.100633","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating cost and care: A qualitative study on oncologists\u2019 perspectives on financial toxicity in India","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2025.100633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100633"}}